Drug class
Leptin Hormone Analogs
Leptin hormone analogs are a specialized class of recombinant peptide therapeutics engineered to mimic the activity of native human leptin, an adipocyte-derived hormone essential for regulating energy homeostasis, neuroendocrine function, and fat metabolism. Read more about Leptin Hormone Analogs
2 drugs in this class 2 manufacturers
Drugs in Leptin Hormone Analogs
MYALEPT (metreleptin)
Leptin hormone analogs are a specialized class of recombinant peptide therapeutics engineered to mimic the activity of native human leptin, an adipocyte-derived hormone essential for regulating energy homeostasis, neuroendocrine function, and fat metabolism.
These agents exert their therapeutic effect by binding to and activating the transmembrane leptin receptor (ObR), stimulating downstream JAK/STAT signaling pathways to compensate for severe endogenous leptin deficiency.
Clinically represented by metreleptin, the class is primarily indicated as an adjunct to diet for hormone replacement therapy to treat metabolic complications—such as severe insulin resistance, diabetes mellitus, and hypertriglyceridemia—in patients with congenital or acquired generalized lipodystrophy.
-
fda.gov
Leptin hormone analogs are a specialized class of recombinant peptide therapeutics engineered to mimic the activity of native human leptin, an adipocyte-derived hormone essential for regulating energy homeostasis, neuroendocrine function, and fat metabolism
-
nih.gov
Leptin hormone analogs are a specialized class of recombinant peptide therapeutics engineered to mimic the activity of native human leptin, an adipocyte-derived hormone essential for regulating energy homeostasis, neuroendocrine function, and fat metabolism
-
rxlist.com
These agents exert their therapeutic effect by binding to and activating the transmembrane leptin receptor (ObR), stimulating downstream JAK/STAT signaling pathways to compensate for severe endogenous leptin deficiency
-
nih.gov
These agents exert their therapeutic effect by binding to and activating the transmembrane leptin receptor (ObR), stimulating downstream JAK/STAT signaling pathways to compensate for severe endogenous leptin deficiency
-
fda.gov
Clinically represented by metreleptin, the class is primarily indicated as an adjunct to diet for hormone replacement therapy to treat metabolic complications—such as severe insulin resistance, diabetes mellitus, and hypertriglyceridemia—in patients with congenital or acquired generalized lipodystrophy
-
fiercepharma.com
Clinically represented by metreleptin, the class is primarily indicated as an adjunct to diet for hormone replacement therapy to treat metabolic complications—such as severe insulin resistance, diabetes mellitus, and hypertriglyceridemia—in patients with congenital or acquired generalized lipodystrophy
Sign in to follow this class
Following a drug class requires a free Physicians Office Resource account.